SIE

209.9

-1.32%↓

AIR.FR

164.54

-2.12%↓

ENR.DE

151.95

+1.23%↑

RHM

1,462.5

-1.71%↓

HO

240.6

-0.29%↓

SIE

209.9

-1.32%↓

AIR.FR

164.54

-2.12%↓

ENR.DE

151.95

+1.23%↑

RHM

1,462.5

-1.71%↓

HO

240.6

-0.29%↓

SIE

209.9

-1.32%↓

AIR.FR

164.54

-2.12%↓

ENR.DE

151.95

+1.23%↑

RHM

1,462.5

-1.71%↓

HO

240.6

-0.29%↓

SIE

209.9

-1.32%↓

AIR.FR

164.54

-2.12%↓

ENR.DE

151.95

+1.23%↑

RHM

1,462.5

-1.71%↓

HO

240.6

-0.29%↓

SIE

209.9

-1.32%↓

AIR.FR

164.54

-2.12%↓

ENR.DE

151.95

+1.23%↑

RHM

1,462.5

-1.71%↓

HO

240.6

-0.29%↓

Search

SPIE SA.

Ouvert

SecteurIndustrie

44 -2.83

Résumé

Variation du prix de l'action

24h

Actuel

Min

43.54

Max

45.44

Chiffres clés

By Trading Economics

Revenu

203M

190M

Ventes

350M

5.4B

P/E

Moyenne du Secteur

44.519

61.065

Rendement du dividende

2.34

Marge bénéficiaire

3.512

Employés

54,673

EBITDA

317M

629M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+24.6% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.34%

2.23%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-987M

7.9B

Ouverture précédente

46.83

Clôture précédente

44

Sentiment de l'Actualité

By Acuity

70%

30%

379 / 406 Classement par Industrials

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

SPIE SA. Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 mars 2026, 23:47 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mars 2026, 22:55 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mars 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mars 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mars 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mars 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mars 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mars 2026, 22:42 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

23 mars 2026, 22:42 UTC

Market Talk
Principaux Événements d'Actualité

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mars 2026, 22:40 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mars 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mars 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mars 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mars 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mars 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mars 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mars 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mars 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mars 2026, 22:18 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mars 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mars 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mars 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mars 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mars 2026, 21:10 UTC

Principaux Événements d'Actualité

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mars 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mars 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mars 2026, 20:50 UTC

Market Talk
Résultats
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

Comparaison

Variation de prix

SPIE SA. prévision

Objectif de Prix

By TipRanks

24.6% hausse

Prévisions sur 12 Mois

Moyen 54 EUR  24.6%

Haut 57 EUR

Bas 51 EUR

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

1

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

43.14 / 43.96Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

379 / 406Classement par Industrie

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos SPIE SA.

SPIE SA provides multi-technical services in the areas of energy and communications in France, Germany, the Netherlands, and internationally. The company operates through four segments: France; Germany and Central Europe; North-Western Europe; and Oil & Gas and Nuclear. It provides building modelling and design services; IT maintenance and managed services; information and communications technology engineering and consulting services; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients, as well as in the areas of electrical and security, HVAC, and information and communications technology; and electrical, mechanical, and HVAC engineering services. The company also offers building information modelling, building management systems, augmented reality, IoT and data management, and smart maintenance services; oil and gas services; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, and tech FM services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. In addition, it engages in the analysis of site conditions; planning, installation, and commissioning of technology; mechanical and industrial robotic solutions; and provision of electric solutions comprising lighting, street lighting, safety and security, prefabrication, and signage solutions. SPIE SA was founded in 1900 and is headquartered in Cergy-Pontoise, France.
help-icon Live chat